2004
Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities
Garfein R, Monterroso E, Tong T, Vlahov D, Des Jarlais D, Selwyn P, Kerndt P, Word C, Fernando M, Ouellet L, Holmberg S. Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. Journal Of Urban Health 2004, 81: 260-267. PMID: 15136659, PMCID: PMC3456450, DOI: 10.1093/jurban/jth112.Peer-Reviewed Original ResearchConceptsInjection drug usersRisk behaviorsHIV seroprevalenceHigh human immunodeficiency virus (HIV) seroprevalenceDrug usersHIV infection risk behaviorsHuman immunodeficiency virus (HIV) seroprevalenceInfection risk behaviorsPotential risk factorsHIV risk behaviorsHIV incidenceHIV statusRisk factorsVirus seroprevalenceSexual partnersPrevention effortsSeroprevalenceBaseline dataHIVFace interviewsInjectionNew York CityFurther effortsNew HavenParticipants
2003
Variability in the Incidence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection among Young Injecting Drug Users in New York City
Des Jarlais D, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, Rockwell R, Edwards V, Friedman S, Monterroso E, Williams I, Garfein R. Variability in the Incidence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection among Young Injecting Drug Users in New York City. American Journal Of Epidemiology 2003, 157: 467-471. PMID: 12615611, DOI: 10.1093/aje/kwf222.Peer-Reviewed Original ResearchConceptsHepatitis B virusHuman immunodeficiency virusHepatitis C virusImmunodeficiency virusB virusDrug usersHepatitis C virus infectionC virus infectionInjecting Drug UsersHigh HIV seroprevalenceHigh rateHBV incidenceHCV incidenceHCV transmissionCohort studyHIV seroprevalenceHIV incidenceHIV transmissionYoung Injecting Drug UsersC virusVirus infectionNew York CityIncidenceVirusYork City
2002
Factors Associated with HIV Seroprevalence among Participants Enrolling at a Needle Exchange Program
Vertefeuille J, Strathdee S, Huettner S, Brown M, Vlahov D. Factors Associated with HIV Seroprevalence among Participants Enrolling at a Needle Exchange Program. Journal Of Drug Issues 2002, 32: 1125-1138. DOI: 10.1177/002204260203200408.Peer-Reviewed Original ResearchInjection drug usersHIV seroprevalenceHIV-seronegative counterpartsHIV-seropositive individualsHIV risk factorsDaily cocaine injectionsDaily heroin injectionDrug use characteristicsHarms of drugsHIV seropositive statusNeedle exchange programsLogistic regression modelsSpeedball injectionHIV antibodiesHIV infectionHeroin injectionProspective studyRisk factorsCocaine injectionFactors AssociatedDrug usersMultivariate modelProgram entryHIVSeroprevalenceHigh-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study
Fuller C, Vlahov D, Ompad D, Shah N, Arria A, Strathdee S. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug And Alcohol Dependence 2002, 66: 189-198. PMID: 11906806, DOI: 10.1016/s0376-8716(01)00200-9.Peer-Reviewed Original ResearchConceptsInjection drug usersInjection drug useAge-matched case-control analysisDrug usersDrug useBlood-borne infectionsAge-matched personsCase-control studyConditional logistic regressionCase-control analysisHigh-risk behaviorsNon-injection heroinCharacteristics of personsHIV seroprevalenceCohort studyInjection useAdult drug usersLogistic regressionPrevention effortsSame calendar timeYoung adult drug usersCalendar timePrior yearAfrican AmericansBaseline
2000
The prevalence of homelessness among injection drug users with and without HIV infection
Song J, Safaeian M, Strathdee S, Vlahov D, Celentano D. The prevalence of homelessness among injection drug users with and without HIV infection. Journal Of Urban Health 2000, 77: 678-687. PMID: 11194310, PMCID: PMC3456762, DOI: 10.1007/bf02344031.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusInjection drug usersInjection drug useIndependent predictorsDrug usersDrug useActive injection drug useLongitudinal cohort studyCross-sectional studyHIV/AIDSCross-sectional investigationHIV seroconversionCohort studyHIV seroprevalenceHIV infectionPrevalence of homelessnessImmunodeficiency virusMale sexLogistic regressionPrevalenceParticipantsMore experiencePredictorsSeroconversionSerostatus
1994
Voluntary Testing for Human Immunodeficiency Virus (HIV) in a Prison Population with a High Prevalence of HIV
Behrendt C, Kendig N, Dambita C, Horman J, Lowlor J, Vlahov D. Voluntary Testing for Human Immunodeficiency Virus (HIV) in a Prison Population with a High Prevalence of HIV. American Journal Of Epidemiology 1994, 139: 918-926. PMID: 8166142, DOI: 10.1093/oxfordjournals.aje.a117098.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHIV-seropositive inmatesVoluntary testingHIV seroprevalenceImmunodeficiency virusCurrent syphilis infectionHigh HIV seroprevalenceSimilar risk factorsMandatory HIV testingSyphilis infectionHIV infectionHIV serosurveyHIV testingRisk factorsHigh prevalencePrison entrantsLower riskPrison populationHigh-risk inmatesDrug useSimilar screeningRisk inmatesSeroprevalenceSerosurveyInfection
1991
New Evidence on Intravenous Cocaine Use and the Risk of Infection with Human Immunodeficiency Virus Type 1
Anthony J, Vlahov D, Nelson K, Conn S, Astemborski J, Solomon L. New Evidence on Intravenous Cocaine Use and the Risk of Infection with Human Immunodeficiency Virus Type 1. American Journal Of Epidemiology 1991, 134: 1175-1189. PMID: 1746528, DOI: 10.1093/oxfordjournals.aje.a116021.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBaltimoreBiasCausalityCocaineConfounding Factors, EpidemiologicFemaleHealth BehaviorHIV InfectionsHIV SeroprevalenceHIV-1HumansLogistic ModelsMiddle AgedPredictive Value of TestsPrevalenceProspective StudiesSexual BehaviorSubstance Abuse, IntravenousSurveys and QuestionnairesConceptsIntravenous drug usersDrug treatment programsCocaine injectorsDrug usersHIV seroprevalenceHIV infectionHuman immunodeficiency virus type 1 (HIV-1) infectionTreatment programActive intravenous drug usersHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Preliminary prospective dataIntravenous cocaine useType 1 infectionReceptive anal intercourseMultiple logistic regressionRisk of infectionVirus type 1HIV seroconversionPresent studyExcess riskProspective dataIntravenous usePresent study sampleHuman Immunodeficiency Virus Infection in Diabetic Intravenous Drug Users
Nelson K, Vlahov D, Cohn S, Lindsay A, Solomon L, Anthony J. Human Immunodeficiency Virus Infection in Diabetic Intravenous Drug Users. JAMA 1991, 266: 2259-2261. PMID: 1920726, DOI: 10.1001/jama.1991.03470160091038.Peer-Reviewed Original ResearchConceptsHistory of diabetesIntravenous drug usersDrug usersHIV seroprevalenceDrug useHuman immunodeficiency virus (HIV) seroprevalenceHuman immunodeficiency virus (HIV) infectionLow HIV seroprevalenceImmunodeficiency virus infectionSafe injection practicesApparent protective effectSterile injection equipmentCross-sectional surveyHIV infectionStudy clinicInjection paraphernaliaVirus seroprevalenceVirus infectionDrug treatmentProtective effectInjection practicesDiabetesPast monthSeroprevalenceSimilar durationSexually Transmitted Diseases in a Population of Intravenous Drug Users: Association with Seropositivity to the Human Immunodeficiency Virus (HIV)
Nelson K, Vlahov D, Cohn S, Odunmbaku M, Lindsay A, Anthony J, Hook E. Sexually Transmitted Diseases in a Population of Intravenous Drug Users: Association with Seropositivity to the Human Immunodeficiency Virus (HIV). The Journal Of Infectious Diseases 1991, 164: 457-463. PMID: 1869836, DOI: 10.1093/infdis/164.3.457.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virusHistory of syphilisHIV seropositivityDrug usersMultivariate analysisHeterosexual intravenous drug usersHuman immunodeficiency virus seropositivityMale intravenous drug usersEvidence of STDUnsafe sex practicesDrug use practicesHIV seroprevalenceHIV infectionImmunodeficiency virusVirus seropositivityPhysical examinationSexual transmissionCocaine injectionSeropositivitySex partnersSignificant associationSex practicesBisexual menSexual intercourse